The patient with the SMAD4 pathogenic variant was evaluated for hereditary hemorrhagic telangiectasia (HHT) and commenced upper gastrointestinal (GI) surveillance in addition to lower GI surveillance. The gene discussed is SMAD4; the disease is hereditary hemorrhagic telangiectasia.